Monthly Archives: November 2019

Europe approves Merck’s Ebola Vaccine

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #40     Merck receives European Approval for Ervebo its Ebola Vaccine       On Monday, the European Commission approved Merck’s Ervebo, known as V920, the world’s first Ebola vaccine, just a few days after the European Medicines Agency’s Committee for […]

read more

Parallèles entre exploration spatiale et exploration du cerveau

      Parallèles entre exploration spatiale et exploration du cerveau   Posté le 6 novembre 2019 dans Communiqués de presse par Charles Sagnes.   L’exploration spatiale et l’exploration du cerveau, deux domaines qui semblent très éloignés sur le papier, ont, en fait, beaucoup de points communs et peuvent chacun apprendre l’un de l’autre pour le futur. […]

read more

China approves Oligomannate for the treatment of Alzheimer’s disease

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #38     China approves Oligomannate for the treatment of Alzheimer’s disease     Shanghai Green Valley Pharmaceuticals (Green Valley) announced that China’s National Medical Products Administration (NMPA) has given a conditional approval to Oligomannate (GV-971) as a new drug for the […]

read more

Hahn nominated as the next US FDA Commissioner

  Btobioinnovation.com Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com     SPECIAL REPORT #37       Stephen Hahn selected to become the next US FDA Commissioner       President Donald Trump has nominated Stephen Hahn as the next US FDA commissioner. Hahn, a radiation oncologist is currently chief medical executive of the University […]

read more